Peña CDD, Bosque CJ, Padilla GAI

Language: Spanish
References: 35
Page: 82-91
PDF size: 314.83 Kb.

ABSTRACT

Choledocholithiasis, defined as stones within the bile duct, is a condition with high morbidity. Currently, endoscopic retrograde cholangiopancreatography is the method of choice for the treatment of choledocholithiasis. However, complications resulting from the procedure can even be fatal. In 2010, the American Society of Gastrointestinal Endoscopy and the Society of American Gastrointestinal and Endoscopic Surgeons issued clinical guidelines as a non-invasive prediction system for the diagnosis of choledocholithiasis according to the clinical, biochemical and imaging characteristics of the patients. The diagnostic performance of the ASGE 2010 predictors for choledocholithiasis is limited, for this reason in 2019, the ASGE issues guidelines on the endoscopic management of choledocholithiasis. Modified individual predictors of choledocholithiasis to improve predictive performance. The literature on the diagnostic performance of these guidelines is limited. This systematic review is carried out to collect information that reports on the diagnostic performance of these guidelines in the world population five years after their issuance.

REFERENCES

1. Machain GM, Arellano ND, Melgarejo SL, Páez LI, Cáceres ME. Predictores de coledocolitiasis en pacientes con litiasis vesicular sintomática tratados en la Segunda Cátedra de Clínica Quirúrgica, Hospital de Clínicas, San Lorenzo año 2017-2019. Fac Cienc Méd Asunción. 2021; 54: 101-108.

2. ASGE Standards of Practice Committee, Buxbaum JL, Abbas Fehmi SM, Sultan S, Fishman DS, Qumseya BJ, et al. ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasis. Gastrointest Endosc. 2019; 89: 1075-1105.e15.

3. Dalai C, Azizian JM, Trieu H, Rajan A, Chen FC, Dong T, et al. Machine learning models compared to existing criteria for noninvasive prediction of endoscopic retrograde cholangiopancreatography-confirmed choledocholithiasis. Liver Res. 2021; 5: 224-231.

4. AbiMansour JP, Martin JA. Biliary endoscopic retrograde cholangiopancreatography. Gastroenterol Clin North Am. 2024; 53: 627-642. Disponible en: https://www.sciencedirect.com/science/article/pii/S0889855324000529

5. Kadah A, Khoury T, Mahamid M, Assy N, Sbeit W. Predicting common bile duct stones by non-invasive parameters. Hepatobiliary Pancreat Dis Int HBPD INT. 2020; 19: 266-270.

6. Mariani A, Segato S, Anderloni A, Cengia G, Parravicini M, Staiano T, et al. Prospective evaluation of ERCP performance in an Italian regional database study. Dig Liver Dis. 2019; 51: 978-984.

7. de Jesús-Flores A, Guerrero-Martínez GA. Impacto del protocolo propuesto por la American Society for Gastrointestinal Endoscopy en pacientes de alto riesgo de coledocolitiasis en el Hospital Regional ISSSTE Puebla en México. Cir Cir. 2019; 87: 1934.

8. Tracy BM, Poulose BK, Paterson CW, Mendoza AE, Gaitanidis A, Saxe JM, et al. National adherence to the ASGE-SAGES guidelines for managing suspected choledocholithiasis: an EAST multicenter study. J Trauma Acute Care Surg. 2022; 92: 305-312.

9. Jacob JS, Lee ME, Chew EY, Thrift AP, Sealock RJ. Evaluating the revised American Society for Gastrointestinal Endoscopy guidelines for common bile duct stone diagnosis. Clin Endosc. 2021; 54: 269-274.

10. Ramírez-Peña T, Vargas-Rubio RD, Lombo CE, Rodríguez-Hortua LM, Muñoz-Velandia OM. Dynamic changes in liver function tests do not correctly reclassify patients at risk of choledocholithiasis beyond ASGE 2019 criteria. Ther Adv Gastrointest Endosc. 2023; 16: 26317745231202869.

11. Steinway SN, Tang B, Telezing J, Ashok A, Kamal A, Yu CY, et al. A machine learning-based choledocholithiasis prediction tool to improve ERCP decision making: a proof-of-concept study. Endoscopy. 2024; 56: 165-171.

12. Ovalle-Chao C, Guajardo-Nieto DA, Elizondo-Pereo RA. Rendimiento de los criterios predictivos de la Sociedad Americana de Endoscopia Gastrointestinal en el diagnóstico de coledocolitiasis en un hospital público de segundo nivel del Estado de Nuevo León, México. Rev Gastroenterol México. 2023; 88: 322-332.

13. Girón F, Rodríguez LM, Conde D, Rey-Chaves CE, Vanegas M, Venegas D, et al. Intermediate risk of choledocholithiasis: are we on the right path? Ann Med Surg (Lond). 2023; 85: 659-664.

14. Mattila A, Helminen O, Pynnonen E, Sironen A, Elomaa E, Nevalainen M. Preoperative MRCP can rule out choledocholithiasis in acute cholecystitis with a high negative predictive value: prospective cohort study with intraoperative cholangiography. J Gastrointest Surg. 2023; 27: 2396-2402.

15. Keczer B, Dubravcsik Z, Szepes A, Madácsy L, Szijártó A, Hritz I. Diagnostic sensitivity of endoscopic ultrasonography in patients with suspected choledocholithiasis. Orv Hetil. 2022; 163: 400-406.

16. Yao L, Zhang J, Liu J, Zhu L, Ding X, Chen D, et al. A deep learning-based system for bile duct annotation and station recognition in linear endoscopic ultrasound. eBioMedicine. 2021; 65: 103238. Disponible en: https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00031-1/fulltext

17. Lee HW, Song TJ, Park DH, Lee SS, Seo DW, Lee SK, et al. Diagnostic performance of the current risk-stratified approach with computed tomography for suspected choledocholithiasis and its options when negative finding. Hepatobiliary Pancreat Dis Int. 2019; 18: 366-372.

18. Chandran A, Rashtak S, Patil P, Gottlieb A, Bernstam E, Guha S, et al. Comparing diagnostic accuracy of current practice guidelines in predicting choledocholithiasis: outcomes from a large healthcare system comprising both academic and community settings. Gastrointest Endosc. 2021; 93: 1351-1359.

19. Blum J, Wood L, Turner R. Artificial intelligence in the detection of choledocholithiasis: a systematic review. HPB (Oxford). 2025; 27: 1-9. Disponible en: https://www.sciencedirect.com/science/article/pii/S1365182X24023268

20. Silva-Santisteban A, Shah I, Chandnani M, Wadhwa V, Tsai L, Bezuidenhout AF, et al. Prospective assessment of the accuracy of ASGE and ESGE guidelines for choledocholithiasis. Endosc Int Open. 2023; 11: E599-E606.

21. Tunruttanakul S, Chareonsil B, Verasmith K, Patumanond J, Mingmalairak C. Evaluation of the American Society of Gastrointestinal Endoscopy 2019 and the European Society of Gastrointestinal Endoscopy guidelines' performances for choledocholithiasis prediction in clinically suspected patients: a retrospective cohort study. JGH Open Open Access J Gastroenterol Hepatol. 2022; 6: 434-440.

22. Wangchuk K, Srichan P. Accuracy of SAGES, ASGE, and ESGE criteria in predicting choledocholithiasis. Surg Endosc. 2022; 36: 7233-7239.

23. Hasak S, McHenry S, Busebee B, Fatima S, Sloan I, Weaver M, et al. Validation of choledocholithiasis predictors from the "2019 ASGE Guideline for the role of endoscopy in the evaluation and management of choledocholithiasis". Surg Endosc. 2022; 36: 4199-4206.

24. Woo JH, Cho H, Ryu K, Choi YW, Lee S, Lee TH, et al. Predictors of choledocholithiasis in cholecystectomy patients and their cutoff values and prediction model in Korea in comparison with the 2019 ASGE Guidelines. Gut Liver. 2024; 18: 1060-1068.

25. Cerne ZP, Sever N, Strnisa L, Plut S, Drnovsek J, Hanzel J, Siuka D, Stabuc B, Drobne D. Performance of European and American Societies of Gastrointestinal Endoscopy guidelines for prediction of choledocholithiasis in patients with acute biliary pancreatitis. Medicina (Kaunas). 2023; 59: 2176.

26. Reddy S, Jagtap N, Kalapala R, Ramchandani M, Lakhtakia S, Basha J, et al. Choledocholithiasis in acute calculous cholecystitis: guidelines and beyond. Ann Gastroenterol. 2021; 34: 247-252.

27. Sousa M, Pinho R, Proenca L, Rodrigues J, Silva J, Gomes C, et al. ASGE high-risk criteria for choledocholithiasis - Are they applicable in cholecystectomized patients? Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2019; 51: 75-78.

28. Ko C, Buxbaum J. Do the 2019 ASGE choledocholithiasis guidelines reduce diagnostic ERCP? Gastrointest Endosc. 2021; 93: 1360-1361.

29. Chisholm PR, Patel AH, Law RJ, Schulman AR, Bedi AO, Kwon RS, et al. Preoperative predictors of choledocholithiasis in patients presenting with acute calculous cholecystitis. Gastrointest Endosc. 2019; 89: 977-983.e2.

30. Hall C, Regner JL, Schroeppel T, Rodriguez J, McIntyre R, Wright F, et al. Protocol driven management of suspected common duct stones: a Southwestern Surgical Congress multi-centered trial. Am J Surg. 2019; 218: 1152-1155.

31. Sadeghi A, Asadzadeh-Aghdaei H, Ketabi-Moghadam P, Rahmani K, Rajabnia M, Salehi N, et al. Evaluation of ASGE criteria for prediction of choledocholithiasis: can early endoscopic ultrasound utilization make the prediction more accurate? Med J Islam Repub Iran. 2023; 37: 2.

32. Jagtap N, Hs Y, Tandan M, Basha J, Chavan R, Nabi Z, et al. Clinical utility of ESGE and ASGE guidelines for prediction of suspected choledocholithiasis in patients undergoing cholecystectomy. Endoscopy. 2020; 52: 569-573.

33. Rashtak S, Goyal H, Chandran A, Dedania B, Patil P, Wadhwa V, et al. Practice patterns and adherence to society guidelines for suspected choledocholithiasis: a comparison of academic and community settings from a large US healthcare system. Front Med. 2022; 9: 1000368.

34. Blum J, Hunn S, Smith J, Chan FY, Turner R. Using artificial intelligence to predict choledocholithiasis: can machine learning models abate the use of MRCP in patients with biliary dysfunction? ANZ J Surg. 2024; 94: 1260-1265.

35. Akshintala VS, Tang B, Kamal A, Buxbaum JL, Elmunzer BJ, Wani SB, et al. Sa1470 Risk estimation, machine learning based ERCP decision-making tool for suspected choledocholithiasis. Gastrointest Endosc. 2019; 89: AB246-AB247.